UBS Wealth Management (WM) makes strides in impact investing through its recent collaboration to push development for cancer cures. The Swiss private bank announced that it will work with MPM Capital, a bioventure investment firm, to help with academic research and better access to cancer care in the developing world. The drive spotlights impact investing – a nascent but increasingly…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]
Have a confidential tip? Get in touch [email protected]
